Zepbound Wegovy Comparison - Search News

Order byBest matchMost fresh

News

Zepbound beats Wegovy for weight loss

Zepbound beats Wegovy for weight loss in trial of blockbuster drugs

Eli Lilly’s obesity drug Zepbound led to nearly 50 percent more weight loss than Novo Nordisk’s Wegovy in the first direct comparison of the two blockbuster medications

Continue reading

Amazon S3 on MSN · 2d

Zepbound beats Wegovy for weight loss in first head-to-head trial of GLP-1 drugs

EconoTimes · 3d

Eli Lilly’s Zepbound Outperforms Wegovy in Weight Loss Head-to-Head Trial

MedPage Today on MSN2d

Zepbound and Wegovy Go Head to Head for Obesity: And the Winner Is ...

Tirzepatide (Zepbound) came out on top against semaglutide (Wegovy) for treating obesity in the head-to-head SURMOUNT-5 trial ...

3d

Mounjaro helps users lose more weight than Wegovy, new trial reveals

GLP-1 drug Zepbound leads to greater weight and waist loss than Wegovy in 72-week trial, say researchers at European Congress ...

Dual-target weight-loss drug is 47% more effective than its rival

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results